In late 2015, Arkema, one of the largest specialty chemical and advanced materials developers, announced that it would be increasing its focus on 3D printing materials research. The company, which hopes that its advanced materials will eventually account for over 25% of its sales, has been busy making good on this announcement, and today, it announced a major investment plan in its biosourced polyamide 11 chain, in hopes of increasing its production capacities for the material in Asia. The investment plan - €300 million over the next five years to build a world-scale plant in the region - is right on track with the company's strategy of ramping up its development of advanced materials for 3D printing. Additionally, Arkema is increasing the production capacity of photocure resins at its Sartomer subsidiary in China by over 30%. Read more at 3DPrint.com: http://3dprint.com/180807/arkema-inv...int-materials/